Orange Book product · Generic (ANDA)
TRETINOIN
TRETINOIN
At a glance
Mar 25, 2026
Approved
Generic (ANDA)
Application
AB1
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Mar 25, 2026
3 mo ago
Today
Pharmaceutical detail
Active ingredient
TRETINOIN
Strength
0.05%
Dosage form
CREAM
Route
TOPICAL
TE code
AB1
Application
ANDA 217832
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of TRETINOIN
- 2018ALTRENOBrand (NDA)
NDA 209353 · DOW PHARM
- 2007ATRALINBrand (NDA)
NDA 022070 · DOW PHARM
- 2002RETIN-A MICROBrand (NDA)
NDA 020475 · BAUSCH
- 2000RENOVABrand (NDA)
NDA 021108 · VALEANT PHARMS NORTH
- 1998AVITABrand (NDA)
NDA 020400 · RISING
- 1997AVITABrand (NDA)
NDA 020404 · MYLAN PHARMS INC
- 1995RENOVABrand (NDA)
NDA 019963 · VALEANT PHARMS NORTH
- 1995VESANOIDBrand (NDA)
NDA 020438 · CHEPLAPHARM
- 1988RETIN-ABrand (NDA)
NDA 019049 · BAUSCH
- —RETIN-ABrand (NDA)
NDA 017522 · VALEANT BERMUDA
- —RETIN-ABrand (NDA)
NDA 017340 · VALEANT PHARMS NORTH
- —RETIN-ABrand (NDA)
NDA 017955 · BAUSCH
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
